CALDOLORĀ® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), today announced an important update regarding its Caldolor® (ibuprofen) Injection. The product's permanent J-code, J1741, is now officially associated with a reimbursement price, providing healthcare providers with a CMS-covered, non-opioid option for managing pain and fever. As the nation continues to face an opioid crisis, non-opioid alternatives, like Caldolor, play […]

Canadian Investment Regulatory Organization Trade Resumption – TCL.B

Trading resumes in: Company: Transcontinental Inc. TSX Symbol: TCL.B All Issues: Yes Resumption (ET): 8:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

UMC Utrecht Selects PathAI’s AISight(R) Dx to Accelerate Research on AI Pathology Algorithms

BOSTON, Mass. and UTRECHT, Netherlands, Dec. 08, 2025 (GLOBE NEWSWIRE) — PathAI, a global leader in artificial intelligence and digital pathology solutions, today announced a partnership with University Medical Center Utrecht to deploy AISight(R) Dx, PathAI's digital pathology image management system, to accelerate research on AI algorithms. UMC Utrecht was among the early adopters of

Xanadu Expands Partnership with A*STAR to Advance Photonic Quantum Computing

(NasdaqGM:CHAC), TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, today announced it has signed a Memorandum of Understanding (“MoU”) with the Agency for Science, Technology and Research (“A*STAR”) in Singapore. This agreement builds on Xanadu's existing partnership with A*STAR Institute of Microelectronics (A*STAR IME) and

ALF Launches Partnership with Helio Genomics to Help Millions Affected by Liver Cancer

New At-Home Liver Test Detects Liver Cancer in Early Stages before Symptoms Surface American Liver Foundation(ALF) is pleased to announce a new partnership with Helio Genomics(Helio) that empowers millions of Americans to find out if they are at risk for, or already have, liver cancer. Liver cancer is rapidly becoming a public health crisis and

Canada opens G7 Industry, Digital and Technology Ministers’ Meeting in Montréal

Today, Canada, represented by the HonourableMélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, and the Honourable Evan Solomon, Minister of Artificial Intelligence and Digital Innovation and Minister responsible for the Federal Economic Development Agency for Southern Ontario, opened the G7 Industry, Digital and Technology Ministers' Meeting in Montréal,

YieldMax(R) ETFs Announces Strategic Updates to ULTY, the YieldMax(R) Ultra Option Income Strategy ETF

(NYSE Arca:ULTY), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced a series of strategic updates to the YieldMax(R) Ultra Option Income Strategy ETF (ULTY). ULTY Overview and Core Purpose ULTY is an actively managed exchange traded fund that seeks to generate current income and provide exposure to select U.S. equities through

Canadian Investment Regulatory Organization Trade Resumption – TCL.A

Trading resumes in: Company: Transcontinental Inc. TSX Symbol: TCL.A All Issues: No Resumption (ET): 8:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

Gannet BioChem Achieves Science Based Targets initiative (SBTi) Validation for Near-Term Climate Commitments

Gannet BioChem Achieves Science Based Targets initiative (SBTi) Validation for Near-Term Climate Commitments GlobeNewswire December 08, 2025 Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today announced that the Science Based Targets initiative (SBTi)

New Symptom-Management Guide Offers Practical Support for People Undergoing Metastatic Breast Cancer Treatment

Evidence-based resource fromViver Health, created with Gilead and endorsed by AONN+, now available to U.S. healthcare professionals and at SABCS Viver Health is proud to announce the introduction of Your Guide to Managing Symptoms from Metastatic Breast Cancer Treatment, a take-home, evidence-based educational resource designed to help individuals with metastatic breast cancer manage symptoms associated

Scroll to Top